Novocure Enrolls First Patient in Phase 3 Pivotal Brain Metastases Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. GNK
7. HTFL
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Novocure Enrolls First Patient in Phase 3 Pivotal Brain Metastases Trial
(NASDAQ: NVCR) Delayed: 16.95 --0 (-0%)
Previous Close $16.95    52 Week High $28.95 
Open $16.95    52 Week Low $5.95 
Day High $16.95    P/E N/A 
Day Low $16.95    EPS $0.00 
Volume 463